gold has been researched along with Melanoma in 114 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (9.65) | 18.7374 |
| 1990's | 2 (1.75) | 18.2507 |
| 2000's | 5 (4.39) | 29.6817 |
| 2010's | 47 (41.23) | 24.3611 |
| 2020's | 49 (42.98) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Jiang, Y; Liang, F; Ren, F; Yang, L; Zhang, J; Zhang, X; Zhong, Y | 1 |
| Dong, L; Hussain, M; Li, H; Li, Q; Liang, R; Shen, C; Shen, G; Tao, J; Wang, K; Xie, J; Zhu, J | 1 |
| Conesa, JJ; Jaque, D; Mulens-Arias, V; Rivera-Gil, P; Rovira-Esteva, M; Sanles-Sobrido, M; Xiao, C; Zamora-Perez, P | 1 |
| Li, J; Liu, K; Liu, Y; Lu, S; Su, J; Sun, J; Wang, B; Wang, F; Wang, Z; Wei, Z; Yang, Y; Zhang, H; Zhao, L | 1 |
| Aggarwal, G; Dhingra, GA; Jindal, M; Kaur, M; Nagpal, M; Singh, M | 1 |
| Gao, C; Kwong, CHT; Lee, SMY; Li, J; Lu, S; Wang, Q; Wang, R; Wei, J; Xie, B | 1 |
| Chen, J; Gao, T; Guo, S; Guo, W; Li, C; Ma, J; Shi, Q; Tian, Y; Wang, H; Wang, S; Wang, X; Wu, Z; Yang, Y; Yi, X; You, W | 1 |
| Dehdari Vais, R; Perota, G; Sattarahmady, N; Zahraie, N | 1 |
| Feltis, B; Franich, R; Geso, M; Tabatabaie, F | 1 |
| Ciardulli, MC; Della Porta, G; Guadagno, L; Lamparelli, EP; Longo, P; Longo, R; Mariconda, A; Raimondo, M; Vertuccio, L | 1 |
| Imanparast, A; Mohseni, H; Salarabadi, SS; Sazgarnia, A | 1 |
| Chen, Y; Fei, W; He, Z; Huang, Y; Li, D; Liu, E; Wang, H; Wu, A; Zhang, M; Zheng, C | 1 |
| Atkins, A; Betzer, O; Cohen, CJ; Gao, Y; Motiei, M; Popovtzer, R; Sadan, T; Shamul, A; Shen, M; Shi, X; Yehuda, R | 1 |
| Behren, A; Li, J; Lin, LL; Trau, M; Wang, J; Wang, Y; Wuethrich, A; Zhang, Z | 1 |
| Fang, X; Fu, Q; Li, S; Li, Y; Qiu, X; Wang, P; Wang, X; Wu, X | 1 |
| Chu, B; Dai, L; Deng, H; Han, R; He, X; Jia, Y; Liao, J; Qian, Z; Shi, K; Wei, X; Yang, F | 1 |
| Barbu Tudoran, L; Ghiulai, R; Ivan, V; Milan, A; Mioc, A; Mioc, M; Oprean, C; Prodea, A; Racoviceanu, R; Șoica, C | 1 |
| Bemidinezhad, A; Gheybi, F; Gholamhosseinian, H; Mirzavi, F; Soukhtanloo, M | 1 |
| Azarpira, N; Daneshvar, F; DehdariVais, R; Kayani, Z; Salehi, F; Sattarahmady, N | 1 |
| Ageev, E; Antuganov, D; Karpov, TE; Maistrenko, DN; Muslimov, AR; Peltek, OO; Petrov, A; Postovalova, A; Rogova, A; Stanzhevsky, AA; Timin, AS; Zuev, D; Zyuzin, MV | 1 |
| Amini, SM; Janzadeh, A; Mohamadkazem, M; Moshiri, A; Neshastehriz, A | 1 |
| Chen, X; Feng, T; Ge, Y; Gopinath, SCB; Liu, M; Wu, C; Xu, X; Yi, C; Yu, H; Zhang, W; Zhao, L; Zou, J | 1 |
| Domingo-Diez, J; Guerrero-Martínez, A; Manzaneda-González, V; Megias, D; Ramírez-Castillejo, C; Ramos-Gómez, M; Sánchez-Díez, M; Serrano-Olmedo, J; Souiade, L | 1 |
| Chang, R; Guan, F; He, Y; Liu, K; Yao, M; Zhang, C; Zhao, D | 1 |
| Cai, HH; Chen, L; Chen, S; Huang, X; Jiang, X; Lin, Y; Sha, T; Sun, PH; Xu, J; Zeng, R; Zhang, J; Zhou, H | 1 |
| Jing, J; Luo, F; Wang, X; Xiao, G; Zeng, C; Zhao, Y | 1 |
| Bichaykina, VR; Dubavik, A; Ghanbaja, J; Karpov, TE; Muslimov, AR; Nominé, A; Peltek, OO; Sukhorukov, GB; Timin, AS; Zyuzin, MV | 1 |
| Cheng, Y; Liang, F; Ning, P; Qin, Y; Wang, J; Xu, P | 1 |
| Ayala, OD; Balko, JM; Bardhan, R; Boyd, KL; DeLapp, RC; Johnson, CA; Lin, EC; Mahadevan-Jansen, A; Ou, YC; Rafat, M; Richmond, A; Shae, D; Tantawy, MN; Vilgelm, AE; Webb, JA; Wen, X; Wilson, JT | 1 |
| Evernden, B; Fang, B; Forsyth, PA; Koomen, JM; Law, V; Macaulay, RJB; Smalley, I; Smalley, KSM; Welsh, EA; Wyatt, C | 1 |
| Akbari-Zadeh, H; Attaran, N; Baradaran-Ghahfarokhi, M; Salamat, MR; Shanei, A | 1 |
| Albericio, F; Araya, E; Arias, E; Campos, A; Cancino, J; Corvalan, AH; Cruz, LJ; Guerrero, S; Jorquera-Cordero, C; Kogan, MJ; Lara, P; Lobos-Gonzalez, L; Muñoz, L; Palma-Florez, S; Polakovicova, I; Quest, AFG; Salas-Huenuleo, E; Varas-Godoy, M; Villegas, J | 1 |
| Ariga, K; Bay, BH; Ding, X; Feng, J; Leong, DT; McCoy, RSA; Sevencan, C; Xie, J; Ye, J; Zhang, M; Zhu, J | 1 |
| Bentley, MVLB; Borgheti-Cardoso, LN; Caron, AL; Kravicz, M; Praça, FG; Silvestrini, AVP; Viegas, JSR | 1 |
| Ferraro, P; Lewinska, A; Merola, F; Moros, M; Tino, A; Tortiglione, C; Wnuk, M | 1 |
| Glitza Oliva, IC; Tawbi, HA | 1 |
| Li, P; Liu, Q; Mi, Y; Tang, J; Xu, J; Yang, Q | 1 |
| Du, B; Geng, S; Lou, R; Wang, Q; Yao, H; Ye, W; Yin, Q; Zhou, J | 1 |
| Astilean, S; Borlan, R; Campu, A; Focsan, M; Lerouge, F; Rugina, D; Tie, L | 1 |
| Acevedo-Mackey, D; Acharjee, N; Akhtar, K; Al-Buriahi, MS; Amandi, A; An, Y; Anjum, NA; Asgari, Q; Badiei, B; Baez Vasquez, AY; Bagley, GD; Bahreini, MS; Bajelan, S; Baluja, MQ; Barbieri, MA; Batalha, MA; Bettiol, H; Bhattarai, U; Biset, JC; Bjerg, M; Björnsson, BT; Boag, AM; Borthwick, MS; Boukhris, I; Bragança, MLBM; Breves, JP; Britz-McKibbin, P; Broaddus, RR; Burnell, JE; Camargo, CA; Campo, M; Carlsen, KL; Catchpole, B; Cavalli, L; Chai, C; Chanakya, HN; Chang, AYH; Chantada, A; Chen, W; Chen, X; Chen, Y; Cheng, ZL; Chenoweth, DA; Chhetri, S; Coelho, CCNDS; Coker, ES; Cole, MA; Coniglio, A; Connor, TR; Corbishley, A; D'Arienzo, M; da Silva, AAM; Dai, Y; de Oliveira, BR; Dignac, MF; Dong, A; Dottino, JA; Duo, J; Einarsdottir, IE; Ekanayake, EMDNK; El Fels, L; El Hayany, B; El Shahawy, O; Elliott, RJR; Fabrizi, E; Farkas, K; Fellman, B; Fenoglio, D; Ferrario, M; Flögel, F; Fujiogi, M; Gamage, BD; Ganson, KT; Gao, X; Gärtner, S; Gautam, A; Gautam, S; Gaze, WH; Gosse, JA; Graham, DW; Graham, PA; Guastella, G; Guerrero, S; Gul, M; Guo, B; Guo, X; Gupta, VK; Hafidi, M; Halland, A; Han, W; Hardisty, M; Hasegawa, K; Hess, ST; Heydari, R; Hillary, LS; Holm, R; Huang, L; Jaleh, B; Jayasundara, JASB; Ji, X; Jiang, L; Jones, DL; Kac, G; Kebaili, I; Kelley, JB; Kelum, SHP; Kennedy, LJ; Khan, NA; Khazalpour, S; Khuntia, HK; Kinney, MS; Kommedal, Ø; Koomhin, P; Krawczyk, N; Kæstel, T; Lakmal, MAC; Li, H; Li, K; Li, R; Li, S; Li, W; Li, X; Li, Y; Liang, L; Lin, Y; Lippo, E; Liu, B; Liu, F; Liu, J; Liu, X; Liu, Y; Lodha, D; Loose, DS; López-Meza, P; Lu, F; Lu, KH; Lu, Y; Luo, Y; Ma, B; Malham, SK; Masood, A; Matan, N; McCormick, SD; McDonald, JE; McKenzie, LJ; Melendez, BD; Mikaeili, F; Mir, IR; Mirjalili, MH; Moreno, KP; Moura, IB; Müller, S; Nagata, JM; Nasri, A; Nasrollahzadeh, M; Navarro-Jiménez, E; Nie, E; Nielsen, CU; Nielsen, S; Nøhr, MK; Obeng, B; Odetayo, AA; Ortiz-Barrios, M; Ozgen, C; Pan, X; Parisi, ML; Paskavitz, AL; Patel, AK; Pedersen, M; Pontarollo, N; Potts, CM; Price, C; Pu, Y; Quénéa, K; Rahimi Khonakdari, M; Rather, BA; Raut, P; Regish, AM; Reible, DD; Rezadoost, H; Rizzati, M; Roviello, GN; Roviello, V; Rumpel, C; Sang, J; Sangroula, S; Saraiva, MDCP; Sarker, A; Sayyed, MI; Segoshi, A; Sehar, Z; Shao, X; Shaw, D; Shaw, L; Shekhawat, NS; Shim, JK; Shokouhimehr, M; Short, A; Soliman, PT; Songsamoe, S; Springer-Miller, RH; Stenstad, T; Strobl, E; Sun, R; Syme, H; Thai, L; Tian, G; Tofighi, B; Tonguc, B; Tuyiringire, D; Ulaganathan, N; Ulvestad, E; Varacca, A; Vergalli, S; Verma, DK; Villmones, HC; Wang, D; Wang, H; Wang, J; Wang, L; Wang, M; Wang, S; Wang, Y; Wang, Z; Weedon-Fekjær, H; Weller, SR; West, BE; Wilcox, MH; Wu, W; Wufuer, R; Xia, S; Xiang, H; Xu, H; Yan, L; Yang, RK; Yang, Y; Yates, MS; Ye, Q; Yin, H; Yin, Y; Yuan, Y; Yucesan, M; Yue, W; Zeng, W; Zhang, C; Zhang, D; Zhang, H; Zhang, L; Zhang, Q; Zhang, Y; Zhou, B; Zhou, Y; Zhu, Y; Zhu, Z | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Alamzadeh, Z; Asefnejad, A; Attaran, N; Hendi, N; Shakeri-Zadeh, A | 1 |
| Banstola, A; Emami, F; Jeong, JH; Kim, JO; Ku, SK; Poudel, K; Yook, S | 1 |
| Li, M; Liu, Y; Meng, M; Wang, K; Wang, Z; Yu, F; Zhao, W; Zhu, H | 1 |
| Coelho, JMP; Faísca, P; Ferreira, D; Ferreira, H; Ferreira-Gonçalves, T; Figueiredo, IV; Gaspar, MM; Lopes, J; Reis, CP; Rodrigues, CMP; Silva, CO; Viana, AS | 1 |
| Hur, W; Kim, SN; Seong, GH; Son, SE | 1 |
| Abolmaali, SS; Ahadian, S; Farahavar, G; Javanmardi, S; Khajeh Zadeh, H; Mohammadi-Samani, S; Nadgaran, H; Nejatollahi, F; Safaie, A; Tamaddon, AM; Yousefi, R | 1 |
| Miki, M; Mukai, T; Munekane, M; Munemura, M; Sano, K; Tanaka, T; Yamasaki, T | 1 |
| Acco, A; Bellan, DL; Biscaia, SMP; Borges, BS; Buzzo, JLA; Cardoso, MB; Cristal, AM; da Cruz, AF; de Barros, HR; de Medeiros, LCAS; de Oliveira, CC; Dos Santos, MP; Gonçalves, JP; Grassi, MT; Meneghetti, MR; Nunes, ÁM; Ribeiro, YC; Riegel-Vidotti, IC; Rossi, GR; Simas, FF; Soares, MJ; Trindade, ES | 1 |
| Chen, B; Ge, S; Jia, R; Liu, X; Ouyang, L; Qiao, Y; Ruan, J; Tan, J; Wang, D; Wang, S; Zhuang, A | 1 |
| Chang, Y; Cheng, Y; Feng, Y; Li, X; Liu, N; Sun, X; Zhang, H | 1 |
| Du, B; Li, W; Li, X; Liu, S; Pan, F; Pan, Y; Qin, L; Yang, W; Yang, XY | 1 |
| Ghorbani, M; Goli Ahmadabad, F; Mostaghimi, H; Rezaei, H; Zabihzadeh, M | 1 |
| Choi, BBR; Choi, JH; Hong, JW; Kim, GC; Kim, UK; Lee, HJ; Song, KW | 1 |
| Abkar, M; Bagheri, S; Hassani, M; Kooshki, H; Mirhosseini, SA; Rashidiani, J; Safaie-Qamsari, E; Yasemi, M | 1 |
| Behren, A; Cebon, J; Trau, M; Tsao, SC; Wang, J; Wang, Y | 1 |
| Ahmadieh, H; Alikarami, F; Asadi, S; Balagholi, S; Kanavi, MR; Nosrati, H | 1 |
| Bakhshizadeh, M; Imanparast, A; Salek, R; Sazgarnia, A | 1 |
| de la Zerda, A; Dutta, R; Liba, O; Si, P; SoRelle, ED; Winetraub, Y; Yecies, DW; Yousefi, S; Yuan, E | 1 |
| Albertini, B; Blasi, P; Donnadio, A; Greco, SML; Iraci, N; Mathieu, V; Ricci, M; Schoubben, A; Temperini, A; Van Woensel, M; Wauthoz, N | 1 |
| Barman, S; Bhunia, D; Das, G; Ghosh, S; Gupta, V; Jana, B; Khan, J; Mondal, P; Mukherjee, D | 1 |
| Dvorankova, B; Guselnikova, O; Kakisheva, K; Kalachyova, Y; Lyutakov, O; Postnikov, P; Svorcik, V | 1 |
| Choi, BBR; Hwang, DS; Jeon, HJ; Kim, GC; Kim, UK; Park, KH | 1 |
| Ashtari, K; Majidi, FS; Mehravi, B; Mohammadi, E; Neshasteh-Riz, A; Nouri, S | 1 |
| Ashtari, K; Einali, S; Majidi, F; Mehravi, B; Mohammadi, E; Neshasteh-Riz, A; Nouri, S | 1 |
| Alvi, SB; Appidi, T; Bantal, V; Begum, A; Deepak, BP; Khan, N; Minhas, G; Rajalakshmi, PS; Rengan, AK; Singh, SP; Srivastava, R | 1 |
| Harry, R; Hendley, O; Stone, JW; Wright, DW | 1 |
| Bear, AS; Drezek, RA; Eckels, PC; Foster, AE; Kennedy, LC; Lin, AY; Mattos Almeida, JP; Perna, SK; Young, JK | 1 |
| Esmaily, H; Mohammadi, Z; Rajabi, O; Sadeghi, HR; Sazgarnia, A; Soudmand, S | 1 |
| Andronache, IC; Biersack, B; Kalie, H; Kaps, L; Muenzner, JK; Sasse, F; Schobert, R; Schuppan, D | 1 |
| Gibson, A; Kacperek, A; La Rosa, V; Royle, G | 1 |
| Amschler, K; Erpenbeck, L; Kruss, S; Schön, MP | 1 |
| Bi, FL; Gan, F; Yin, HQ | 1 |
| Gunasekaran, S; Maddodi, N; Seenivasan, R; Setaluri, V | 1 |
| Celli, A; Char, DH; Crosby, MB; Green, GA; Jusufbegovic, D; Latorre, A; Ma, J; Monico, G; Ortiz-Urda, S; Posch, C; Rappersberger, K; Sanlorenzo, M; Somoza, Á; Vujic, I; Weier, J; Zekhtser, M | 1 |
| Fu, S; Li, BX; Li, P; Shi, YW; Shi, ZL; Xu, WC; Zhou, C | 1 |
| Chavva, SR; Jones, S; Kanchanapally, R; Pramanik, A; Ray, PC; Sinha, SS; Tchounwou, C; Viraka Nellore, BP | 1 |
| Choi, BB; Hong, JW; Kim, GC; Kim, MS; Kim, UK; Lee, HJ | 1 |
| Asadi, S; Knaup, C; Masoudi, SF; Meigooni, AS; Rahmani, F; Vaez-zadeh, M | 1 |
| Asadi, S; Marghchouei, M; Masoudi, SF; Vaez-Zadeh, M; Vahidian, M | 1 |
| Duncan, B; Hou, S; Jeong, Y; Jiang, Y; Kim, C; Kim, CS; Kim, ST; Park, MH; Rotello, VM; Saha, K; Tang, R; Yan, B; Yeh, YC | 1 |
| Bani, D; Biagioni, A; Bianchini, F; Calorini, L; Chillà, A; Del Rosso, M; Fibbi, G; Laurenzana, A; Margheri, F; Margheri, G; Olmi, R; Severi, M; Torre, E; Traversi, R; Trigari, S; Zoppi, A | 1 |
| Albrecht, M; Brabec, V; Donnelly, K; Kasparkova, J; Mueller, T; Muenzner, JK; Novohradsky, V; Rehm, T; Schmitt, F; Schobert, R | 1 |
| Kobiela, T; Lekka, M; Milner-Krawczyk, M; Sobiepanek, A | 1 |
| Eynali, S; Iraji Rad, R; Khoei, S; Khoshgard, K; Mousavi, M; Nedaei, HA; Robatjazi, M | 1 |
| Kim, EH; Kim, SR | 1 |
| Atukorale, PU; Bekdemir, A; Irvine, DJ; Moynihan, KD; Rakhra, K; Stellacci, F; Tang, L; Yang, YS | 1 |
| Chong, YS; Chu, Y; Gao, JQ; Huang, YF; Jiang, ZH; Mao, ZW; Niu, J; Peng, LH | 1 |
| Bliss, D; Heymann, JA; Kim, S; Milne, JL; Shi, D; Subramaniam, S | 1 |
| Aravindaram, K; Yang, NS | 1 |
| Inubushi, T; Kamei, K; Kojima, H; Morita, M; Mukai, Y; Nakagawa, S; Okada, N; Seino, S; Yamamoto, TA; Yoshikawa, M; Yoshikawa, T; Yoshioka, Y | 1 |
| Amiri, KI; Harry, SR; Hicks, DJ; Wright, DW | 1 |
| Galanzha, EI; Hennings, L; Nedosekin, DA; Shashkov, EV; Zharov, VP | 1 |
| Domnanich, P; Peña, DB; Preininger, C | 1 |
| Bhattacharyya, K; Kannan, R; Katti, K; McCormack, DR; Viator, JA | 1 |
| Baumgart, J; Boulais, É; Humbert, L; Lachaine, R; Lebrun, JJ; Meunier, M | 1 |
| Cui, D; Fu, S; Li, P; Luo, T; Pang, B; Ren, Q; Xu, W; Zhou, C | 1 |
| Chibli, H; Kong, D; Nadeau, J; Zhang, X | 1 |
| Albertini, M; Gan, J; Hank, J; Heisey, D; Larson, M; Mahvi, DM; Pharo, L; Schalch, H; Schiller, J; Shi, FS; Sondel, PM; Warner, T; Weber, S; Yang, NS | 1 |
| ARIEL, IM; GALEY, D; RESNICK, MI | 1 |
| Ahn, KY; Bae, CS; Hong, EK; Imayama, S; Kim, BY; Ko, SH; Lee, SE; Lee, SW; Nakamura, K; Nam, KI; Park, SS; Park, YJ | 1 |
| Balogh, L; Bolton, B; El-Jawahri, A; Hutson, A; Kariapper, MS; Khan, MK; Lesniak, W; Llanes, M; Mamou, F; Minc, L; Nair, BM; Nigavekar, SS; Sung, LY; Tan, W; Zhang, C | 1 |
| Crooke, ST; Mirabelli, CK | 1 |
| Packer, S; Rotman, M | 2 |
| Leitner, MD; Müller, M; Schöfer, C; Wachtler, F | 1 |
| Blackwell, PM; Markham, R; Usher, G | 1 |
| Kaiserling, E; Metzler, G; Schaumburg-Lever, G | 1 |
| Garrigues, HJ; Hellström, I; Hellström, KE; Lara, S; Lark, MW; Wight, TN | 1 |
| Crooke, ST; Faucette, LF; Girard, GR; Hill, DT; Johnson, RK; Kuo, GY; Mirabelli, CK; Sung, CM | 1 |
| Berners-Price, SJ; Faucette, LF; Giovenella, AJ; Johnson, RK; Mirabelli, CK; Sadler, PJ | 1 |
| Absolon, MJ; Keightley, SJ; Khaw, PT | 1 |
| Bosworth, JL; Finger, PT; Ho, T; Packer, S; Rotman, M | 1 |
| Crooke, ST; Faucette, L; Johnson, RK; Mirabelli, CK; Muirhead, K; Sung, CM | 1 |
5 review(s) available for gold and Melanoma
| Article | Year |
|---|---|
Nanotechnology approaches in the current therapy of skin cancer.
Topics: Administration, Cutaneous; Antineoplastic Agents; Dacarbazine; Drug Carriers; Drug Resistance, Neoplasm; Fluorouracil; Gold; Humans; Melanoma; Metal Nanoparticles; Nanoparticles; Nanotechnology; Particle Size; Skin Absorption; Skin Neoplasms; Skin Physiological Phenomena; Surface Properties | 2020 |
Topics: Acyclic Monoterpenes; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollutants, Occupational; Amino Acid Transport Systems; Analgesics, Opioid; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Arthrobacter; Bacteria; Bacteriological Techniques; Benzaldehydes; Biodegradation, Environmental; Biofilms; Biological Transport; Biomarkers; Biomass; Bioreactors; Body Composition; Body Mass Index; Brassica; Brazil; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Caco-2 Cells; Cadmium; Calcium; Calcium Carbonate; Calcium Channels; Catalysis; Cell Degranulation; Cell Line; Cell Membrane; Chitosan; Chromatography, High Pressure Liquid; Chromium; Cobalt; Cohort Studies; Colony Count, Microbial; Composting; Copper; COVID-19; Cross-Sectional Studies; Cytoplasm; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diarrhea; Diethylhexyl Phthalate; Dose-Response Relationship, Drug; Drug Implants; Drug Stability; Drug Synergism; Electroplating; Endometrial Neoplasms; Endometrium; Environmental Monitoring; Environmental Restoration and Remediation; Estradiol; Estrogens; Feces; Female; Food Microbiology; Food Preservation; Fruit and Vegetable Juices; Gasotransmitters; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gene Expression Regulation, Developmental; Genetic Predisposition to Disease; Glutathione; Gold; Graphite; Growth Hormone; Harm Reduction; Hot Temperature; Humans; Hydrocortisone; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydrogen-Ion Concentration; Ileum; Imidazoles; Injections, Intraperitoneal; Insecticides; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor I; Intestinal Absorption; Light; Lignin; Liver; Magnetics; Male; Manganese; Mast Cells; Melanoma; Membrane Potentials; Metals; Methadone; Microbial Viability; Microplastics; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Middle Aged; Mitochondrial Swelling; Molecular Dynamics Simulation; Monophenol Monooxygenase; Morocco; Naloxone; Naltrexone; Nanocomposites; Nanomedicine; Nanoparticles; Narcotic Antagonists; Neonicotinoids; Nitric Oxide; Nitro Compounds; Nitrogen; Nitrogen Compounds; Obesity; Obesity, Abdominal; Occupational Exposure; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Oryza; Overweight; Oxidative Stress; Oxides; Oxygen; Perception; Photoelectron Spectroscopy; Plants; Plastics; Point Mutation; Polychlorinated Biphenyls; Polycyclic Aromatic Hydrocarbons; Potassium; Premenopause; Prodrugs; Prospective Studies; Protons; Pyrolysis; Qualitative Research; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resins, Synthetic; Rhodamines; Risk Factors; ROC Curve; Salmo salar; SARS-CoV-2; Seawater; Severity of Illness Index; Sewage; Social Media; Soil; Soil Microbiology; Soil Pollutants; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Staining and Labeling; Stainless Steel; Steel; Stress, Physiological; Substance Abuse Treatment Centers; Symporters; T-Lymphocytes; Toluene; Triclosan; Ultraviolet Rays; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Purification; Welding; X-Ray Diffraction; Young Adult | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Using gold nanoparticles in diagnosis and treatment of melanoma cancer.
Topics: Animals; Drug Carriers; Gold; Humans; Melanoma; Metal Nanoparticles; Molecular Targeted Therapy; Nanomedicine | 2018 |
Radiotherapy of choroidal melanoma with iodine 125.
Topics: Aged; Choroid Neoplasms; Follow-Up Studies; Gold; Humans; Iodine Radioisotopes; Male; Melanoma; Middle Aged; Radiotherapy Dosage; Technology, Radiologic | 1980 |
2 trial(s) available for gold and Melanoma
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: report of a phase I/IB study.
Topics: Biolistics; Cancer Vaccines; DNA, Complementary; Dose-Response Relationship, Immunologic; Feasibility Studies; Gold; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypersensitivity, Delayed; Immunologic Factors; Injections, Intradermal; Leiomyosarcoma; Liposarcoma; Melanoma; Safety; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Tumor Cells, Cultured; Vaccines, DNA | 2002 |
108 other study(ies) available for gold and Melanoma
| Article | Year |
|---|---|
Hierarchical dual-responsive cleavable nanosystem for synergetic photodynamic/photothermal therapy against melanoma.
Topics: Cell Line, Tumor; Gold; Humans; Melanoma; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Phototherapy; Photothermal Therapy | 2021 |
Photosensitizer-loaded gold nanocages for immunogenic phototherapy of aggressive melanoma.
Topics: Cell Line, Tumor; Gold; Humans; Indocyanine Green; Lipid Bilayers; Melanoma; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Phototherapy | 2022 |
Multiphoton imaging of melanoma 3D models with plasmonic nanocapsules.
Topics: Cell Line, Tumor; Gold; Humans; Hypoxia; Melanoma; Nanocapsules; Reactive Oxygen Species | 2022 |
An Engineered Protein-Au Bioplaster for Efficient Skin Tumor Therapy.
Topics: Cell Line, Tumor; Gold; Humans; Melanoma; Nanotubes; Neoplasm Recurrence, Local; Phototherapy; Polypyrimidine Tract-Binding Protein; Skin Neoplasms | 2022 |
Skin Cancer Management: Current Scenario And Future Perspectives.
Topics: Gold; Humans; Melanoma; Melanoma, Cutaneous Malignant; Metal Nanoparticles; Nanotubes, Carbon; Skin Neoplasms | 2023 |
In vivo hitchhiking of immune cells by intracellular self-assembly of bacteria-mimetic nanomedicine for targeted therapy of melanoma.
Topics: Bacteria; Cell Line, Tumor; Gold; Humans; Melanoma; Metal Nanoparticles; Nanomedicine; Nanoparticles; Neoplasms; Tumor Microenvironment | 2022 |
Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Ferroptosis; Gold; Humans; Immunotherapy; Melanoma; Metal Nanoparticles; Mice; MicroRNAs | 2022 |
Simultaneous chemotherapy/sonodynamic therapy of the melanoma cancer cells using a gold-paclitaxel nanostructure.
Topics: Cell Line, Tumor; Gold; Humans; Melanoma; Metal Nanoparticles; Nanoparticles; Paclitaxel; Photochemotherapy | 2022 |
Oxidative Damage to Mitochondria Enhanced by Ionising Radiation and Gold Nanoparticles in Cancer Cells.
Topics: Gold; Humans; Melanoma; Metal Nanoparticles; Mitochondria; Oxidative Stress; Radiation, Ionizing; Reactive Oxygen Species | 2022 |
Electrospun Membranes Designed for Burst Release of New Gold-Complexes Inducing Apoptosis of Melanoma Cells.
Topics: Apoptosis; Gold; Humans; Melanoma; Membranes; Nanofibers; Polyesters | 2022 |
In vitro evaluation of the intensifying photodynamic effect due to the presence of plasmonic hollow gold nanoshells loaded with methylene blue on breast and melanoma cancer cells.
Topics: Gold; Humans; Melanoma; Methylene Blue; Nanoshells; Photochemotherapy; Photosensitizing Agents | 2022 |
Gold Nanocage-Based Photothermal Ablation Facilitates In Situ Vaccination for Melanoma Therapy.
Topics: Adjuvants, Immunologic; Animals; B7-H1 Antigen; Cell Line, Tumor; Gold; Immunotherapy; Melanoma; Mice; Tumor Microenvironment; Vaccination | 2022 |
Multifunctional nanoprobe for real-time in vivo monitoring of T cell activation.
Topics: Animals; Calcium; Gold; Humans; Melanoma; Metal Nanoparticles; Mice; T-Lymphocytes | 2022 |
SERS Multiplex Profiling of Melanoma Circulating Tumor Cells for Predicting the Response to Immune Checkpoint Blockade Therapy.
Topics: Alloys; Biomarkers; Gold; Humans; Immune Checkpoint Inhibitors; Interferon-gamma; Melanoma; Neoplastic Cells, Circulating; Silver | 2022 |
Raman spectroscopy combined with deep learning for rapid detection of melanoma at the single cell level.
Topics: Deep Learning; Gold; Humans; Melanoma; Metal Nanoparticles; Spectrum Analysis, Raman | 2023 |
Gold Nanorods and Polymer Micelles Mediated Dual TLR Stimulators Delivery System CPG@Au NRs/M-R848 Regulate Macrophages Reprogramming and DC Maturation for Enhanced Photothermal Immunotherapy of Melanoma.
Topics: Gold; Humans; Immunotherapy; Macrophages; Melanoma; Micelles; Nanotubes | 2023 |
The Antimelanoma Biological Assessment of Triterpenic Acid Functionalized Gold Nanoparticles.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Gold; Humans; Melanoma; Metal Nanoparticles | 2023 |
Gold-containing liposomes and glucose-coated gold nanoparticles enhances the radiosensitivity of B16F0 melanoma cells via increasing apoptosis and ROS production.
Topics: Apoptosis; bcl-2-Associated X Protein; Caspase 3; Glucose; Gold; Humans; Liposomes; Melanoma; Metal Nanoparticles; Radiation Tolerance; Radiation-Sensitizing Agents; Reactive Oxygen Species; RNA, Messenger; Tumor Suppressor Protein p53 | 2023 |
Fractionated Sonodynamic Therapy Using Gold@Poly(ortho-aminophenol) Nanoparticles and Multistep Low-Intensity Ultrasound Irradiation to Treat Melanoma Cancer: In Vitro and In Vivo Studies.
Topics: Animals; Cell Line, Tumor; Gold; Male; Melanoma; Metal Nanoparticles; Mice; Nanoparticles; Reactive Oxygen Species; Ultrasonic Therapy | 2023 |
Development of Nanocarrier-Based Radionuclide and Photothermal Therapy in Combination with Chemotherapy in Melanoma Cancer Treatment.
Topics: Antineoplastic Agents; Cell Line, Tumor; Gold; Humans; Melanoma; Nanotubes; Paclitaxel; Phototherapy; Photothermal Therapy; Radioisotopes | 2023 |
Radiosensitising effect of iron oxide-gold nanocomplex for electron beam therapy of melanoma in vivo by magnetic targeting.
Topics: Animals; Electrons; Ferric Compounds; Gold; Melanoma; Mice | 2023 |
Regulating tumor microenvironments by a lymph node-targeting adjuvant via tumor-specific CTL-derived IFNγ.
Topics: Adjuvants, Immunologic; Animals; Cancer Vaccines; CD8-Positive T-Lymphocytes; Gold; Interferon-gamma; Lipids; Melanoma; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Tumor Microenvironment | 2023 |
Effectiveness of Gold Nanorods of Different Sizes in Photothermal Therapy to Eliminate Melanoma and Glioblastoma Cells.
Topics: Cell Death; Glioblastoma; Gold; Humans; Melanoma; Photothermal Therapy | 2023 |
PMN-incorporated multifunctional chitosan hydrogel for postoperative synergistic photothermal melanoma therapy and skin regeneration.
Topics: Anti-Bacterial Agents; Chitosan; Gold; Humans; Hydrogels; Melanoma; Metal Nanoparticles; Nanogels; Neoplasm Recurrence, Local; Polyphenols; Reactive Oxygen Species | 2023 |
Topics: Animals; Gold; Humans; Melanoma; Melanoma, Cutaneous Malignant; Metal Nanoparticles; Mice; Monophenol Monooxygenase; Skin Neoplasms; Spectrum Analysis, Raman; Wearable Electronic Devices | 2023 |
Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune "cold" tumors.
Topics: Gold; Humans; Hyaluronic Acid; Immune Checkpoint Inhibitors; Melanoma; Nanoparticles; Silicon Dioxide; Tumor Microenvironment | 2023 |
Biomimetic drug delivery platforms based on mesenchymal stem cells impregnated with light-responsive submicron sized carriers.
Topics: Biomimetics; Capsules; Cell Movement; Cell Survival; Drug Delivery Systems; Gold; Humans; Light; Melanoma; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Nanotubes; Particle Size; Primary Cell Culture; Spheroids, Cellular; Tumor Cells, Cultured; Vincristine | 2020 |
Precise control of apoptosis via gold nanostars for dose dependent photothermal therapy of melanoma.
Topics: Animals; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Gold; Humans; Melanoma; Metal Nanoparticles; Mice; Phototherapy | 2019 |
Multimodal Multiplexed Immunoimaging with Nanostars to Detect Multiple Immunomarkers and Monitor Response to Immunotherapies.
Topics: Animals; B7-H1 Antigen; Biomarkers, Tumor; Cell Line, Tumor; Disease Models, Animal; Gold; Immunotherapy; Melanoma; Metal Nanoparticles; Mice; Optical Imaging; Particle Size; Surface Properties; Tumor Necrosis Factor Receptor Superfamily, Member 9 | 2020 |
Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance.
Topics: Disease Progression; Drug Resistance, Neoplasm; Gold; Humans; Melanoma; Phosphatidylinositol 3-Kinases; Proteomics; Tumor Microenvironment | 2020 |
Effect of targeted gold nanoparticles size on acoustic cavitation: An in vitro study on melanoma cells.
Topics: Gold; High-Intensity Focused Ultrasound Ablation; Melanoma; Metal Nanoparticles; Molecular Structure; Particle Size; Tumor Cells, Cultured | 2020 |
Gold nanoparticle based double-labeling of melanoma extracellular vesicles to determine the specificity of uptake by cells and preferential accumulation in small metastatic lung tumors.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Membrane Permeability; Colonic Neoplasms; Extracellular Vesicles; Fluorescent Dyes; Gold; Humans; Lung; Lung Neoplasms; Melanoma; Melanoma, Experimental; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Optical Imaging; Surface Properties; Tissue Distribution | 2020 |
Increasing the Potential Interacting Area of Nanomedicine Enhances Its Homotypic Cancer Targeting Efficacy.
Topics: Animals; Antibiotics, Antineoplastic; Cell Membrane; Cell Proliferation; Cell Survival; Cells, Cultured; Doxorubicin; Drug Screening Assays, Antitumor; Gold; Humans; Melanoma; Mice; Mice, Inbred C57BL; Nanomedicine; Nanostructures; Neoplasms, Experimental; NIH 3T3 Cells; Optical Imaging; Particle Size; Surface Properties | 2020 |
Gold Nanorods and Nanoprisms Mediate Different Photothermal Cell Death Mechanisms In Vitro and In Vivo.
Topics: Animals; Apoptosis; Cell Death; Cell Line, Tumor; Gold; Humans; Hydra; Hyperthermia, Induced; Melanoma; Metal Nanoparticles; Nanotubes; Necrosis; Photothermal Therapy; Surface Plasmon Resonance | 2020 |
"Liquid Gold" - The unTAPped Potential of Cerebrospinal Fluid Analysis?
Topics: Disease Progression; Drug Resistance, Neoplasm; Gold; Humans; Lung Neoplasms; Melanoma; Proteomics | 2020 |
Targeted gold nanorods combined with low-intensity nsPEFs enhance antimelanoma efficacy in vitro.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Combined Modality Therapy; Folic Acid; Gold; Humans; Melanoma; Nanotubes; Pulsed Radiofrequency Treatment; Up-Regulation | 2020 |
ROS-boosted photodynamic therapy against metastatic melanoma by inhibiting the activity of antioxidase and oxygen-producing nano-dopants.
Topics: Animals; Dose-Response Relationship, Drug; Female; Gold; Humans; Melanoma; Melanoma, Experimental; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Oxidative Stress; Oxygen; Photochemotherapy; Reactive Oxygen Species; Skin Neoplasms; Titanium; Xenograft Model Antitumor Assays | 2020 |
ICG-loaded gold nano-bipyramids with NIR activatable dual PTT-PDT therapeutic potential in melanoma cells.
Topics: Gold; Humans; Indocyanine Green; Melanoma; Photochemotherapy | 2020 |
Study of the Parameters Affecting the Loading of Fluorescein on Coated Gold Nanoparticles: Promising Nanostructure for Cancer Diagnosis.
Topics: Animals; Fluorescein; Gold; Melanoma; Metal Nanoparticles; Mice; Microscopy, Fluorescence; Tumor Cells, Cultured | 2021 |
Localized therapy using anti-PD-L1 anchored and NIR-responsive hollow gold nanoshell (HGNS) loaded with doxorubicin (DOX) for the treatment of locally advanced melanoma.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Doxorubicin; Drug Compounding; Drug Liberation; Gold; Humans; Hydrogen-Ion Concentration; Male; Melanoma; Mice, Inbred C57BL; Molecular Targeted Therapy; Nanocapsules; Nanoshells; Photosensitizing Agents; Phototherapy; Surface Properties | 2021 |
The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Neoplasm; Antigens, Neoplasm; Bone Marrow Cells; Cancer Vaccines; Cell Line, Tumor; Cytokines; Cytotoxicity, Immunologic; Dendritic Cells; Female; Galactosylceramides; Gold; Humans; Immune Sera; Melanoma; Metal Nanoparticles; Mice, Inbred BALB C; Mice, Inbred C57BL; Mucin-1; Spleen; T-Lymphocytes, Cytotoxic | 2021 |
Proof-of-Concept Study of Multifunctional Hybrid Nanoparticle System Combined with NIR Laser Irradiation for the Treatment of Melanoma.
Topics: Animals; Cell Line, Tumor; Epidermal Growth Factor; Gold; Humans; Low-Level Light Therapy; Male; Melanoma; Metal Nanoparticles; Mice, SCID; Multifunctional Nanoparticles; Oleic Acid; Proof of Concept Study; Skin Neoplasms; Xenograft Model Antitumor Assays | 2021 |
Cell-based electrochemical cytosensor for rapid and sensitive evaluation of the anticancer effects of saponin on human malignant melanoma cells.
Topics: Antineoplastic Agents; Biosensing Techniques; Cell Line, Tumor; Electrochemistry; Electrodes; Gold; Humans; Limit of Detection; Melanoma; Metal Nanoparticles; Saponins; Time Factors | 2021 |
Single-chain antibody-decorated Au nanocages@liposomal layer nanoprobes for targeted SERS imaging and remote-controlled photothermal therapy of melanoma cancer cells.
Topics: Gold; Humans; Hyperthermia, Induced; Melanoma; Photothermal Therapy; Spectrum Analysis, Raman; Theranostic Nanomedicine | 2021 |
Electrostatically self-assembled gold nanorods with chondroitin sulfate for targeted photothermal therapy for melanoma.
Topics: Cell Line, Tumor; Chondroitin Sulfates; Gold; Humans; Melanoma; Nanotubes; Photochemotherapy; Photosensitizing Agents; Phototherapy; Photothermal Therapy | 2021 |
Biocompatible gum arabic-gold nanorod composite as an effective therapy for mistreated melanomas.
Topics: Animals; BALB 3T3 Cells; Cell Line, Tumor; Cell Proliferation; Cell Survival; Extracellular Matrix; Gold; Gum Arabic; Humans; Lung Neoplasms; Melanoma; Metal Nanoparticles; Mice; Treatment Outcome; Xenograft Model Antitumor Assays | 2021 |
A Novel Stimuli-Responsive Injectable Antibacterial Hydrogel to Achieve Synergetic Photothermal/Gene-Targeted Therapy towards Uveal Melanoma.
Topics: Anti-Bacterial Agents; Drug Delivery Systems; Drug Liberation; Genetic Therapy; Gold; Humans; Hydrogels; Injections; Melanoma; Nanotubes; Photothermal Therapy; Uveal Neoplasms | 2021 |
Simulated Sunlight-Mediated Photodynamic Therapy for Melanoma Skin Cancer by Titanium-Dioxide-Nanoparticle-Gold-Nanocluster-Graphene Heterogeneous Nanocomposites.
Topics: Animals; Female; Gold; Graphite; Melanoma; Melanoma, Experimental; Mice, Inbred BALB C; Nanocomposites; Nanoparticles; Photochemotherapy; Skin Neoplasms; Sunlight; Titanium | 2017 |
Gold nanoparticles attenuate metastasis by tumor vasculature normalization and epithelial-mesenchymal transition inhibition.
Topics: Angiogenesis Inducing Agents; Animals; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Gold; Humans; Lung Neoplasms; Melanoma; Mice, Inbred C57BL; Nanoparticles; Neovascularization, Pathologic; Tumor Hypoxia | 2017 |
Evaluation of dose enhancement in presence of gold nanoparticles in eye brachytherapy by
Topics: Brachytherapy; Computer Simulation; Dose-Response Relationship, Radiation; Eye; Eye Neoplasms; Gold; Humans; Melanoma; Metal Nanoparticles; Palladium; Radioisotopes; Uveal Neoplasms | 2017 |
Selective Killing of Melanoma Cells With Non-Thermal Atmospheric Pressure Plasma and p-FAK Antibody Conjugated Gold Nanoparticles.
Topics: Antibodies; Apoptosis; Cell Line, Tumor; Cell Survival; Focal Adhesion Protein-Tyrosine Kinases; Gold; Humans; Keratinocytes; Melanoma; Metal Nanoparticles; Phosphorylation; Pressure | 2017 |
Characterising the phenotypic evolution of circulating tumour cells during treatment.
Topics: Antibodies, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; CD146 Antigen; Cell Line, Tumor; Cell Tracking; Gene Expression; Gold; Humans; Imidazoles; Immunoconjugates; Immunophenotyping; Melanoma; Metal Nanoparticles; Mitochondrial Proteins; Molecular Targeted Therapy; Neoplastic Cells, Circulating; Nerve Tissue Proteins; Oximes; Phenotype; Primary Cell Culture; Pyridones; Pyrimidinones; Receptor, ErbB-3; Receptors, Nerve Growth Factor; Skin Neoplasms; Spectrum Analysis, Raman; Staining and Labeling | 2018 |
Gamma irradiation of ocular melanoma and lymphoma cells in the presence of gold nanoparticles: in vitro study.
Topics: Brachytherapy; Cell Proliferation; Eye Neoplasms; Gamma Rays; Gold; Humans; In Vitro Techniques; Lymphoma; Melanoma; Metal Nanoparticles; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Uveal Neoplasms | 2018 |
Pegylated hollow gold-mitoxantrone nanoparticles combining photodynamic therapy and chemotherapy of cancer cells.
Topics: Cell Death; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Drug Liberation; Drug Stability; Gold; Humans; Lasers, Semiconductor; MCF-7 Cells; Melanoma; Metal Nanoparticles; Mitoxantrone; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols | 2018 |
Gold Nanoprisms as Optical Coherence Tomography Contrast Agents in the Second Near-Infrared Window for Enhanced Angiography in Live Animals.
Topics: Angiography; Animals; Contrast Media; Erythrocytes; Female; Gold; Infrared Rays; Melanoma; Metal Nanoparticles; Mice; Mice, Nude; Particle Size; Skin; Surface Properties; Tomography, Optical Coherence; Tumor Microenvironment | 2018 |
Tumor Targeting by Peptide-Decorated Gold Nanoparticles.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Flow Cytometry; Glioblastoma; Gold; Integrin alphaVbeta3; Melanoma; Metal Nanoparticles; Mice; Nanomedicine; Polyethylene Glycols | 2019 |
Dual-Arm Nanocapsule Targets Neuropilin-1 Receptor and Microtubule: A Potential Nanomedicine Platform.
Topics: Animals; Apoptosis; Cell Cycle; Cryoelectron Microscopy; Gold; Humans; Melanoma; Metal Nanoparticles; Mice; Microtubules; Nanocapsules; Nanomedicine; Neuropilin-1; Tubulin | 2019 |
Rapid SERS-based recognition of cell secretome on the folic acid-functionalized gold gratings.
Topics: Cancer-Associated Fibroblasts; Cells, Cultured; Folic Acid; Gold; Humans; Melanoma; Metal Nanoparticles; Spectrum Analysis, Raman; Surface Properties; Tumor Cells, Cultured | 2019 |
Induction of Melanoma Cell-Selective Apoptosis Using Anti-HER2 Antibody-Conjugated Gold Nanoparticles.
Topics: Actins; Antibodies; Apoptosis; Apoptosis Inducing Factor; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cytochromes c; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; G1 Phase; Gold; Humans; Melanoma; Metal Nanoparticles; Receptor, ErbB-2 | 2019 |
Investigating the effect of near infrared photo thermal therapy folic acid conjugated gold nano shell on melanoma cancer cell line A375.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Folic Acid; Gold; Humans; Infrared Rays; Melanoma; Metal Nanoparticles; Phototherapy; Silicon Dioxide | 2019 |
NIR triggered glycosylated gold nanoshell as a photothermal agent on melanoma cancer cells.
Topics: Cell Line, Tumor; Glycosylation; Gold; Humans; Infrared Rays; Melanoma; Nanoparticles; Nanoshells; Phototherapy; Silicon Dioxide; Temperature | 2019 |
The "nano to micro" transition of hydrophobic curcumin crystals leading to in situ adjuvant depots for Au-liposome nanoparticle mediated enhanced photothermal therapy.
Topics: Adjuvants, Pharmaceutic; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Chemotherapy, Adjuvant; Crystallization; Curcumin; Female; Gold; Humans; Hydrophobic and Hydrophilic Interactions; Hyperthermia, Induced; Infrared Rays; Liposomes; Melanoma; Metal Nanoparticles; Mice, Inbred C57BL; Particle Size; Phototherapy; Skin Neoplasms; Tumor Microenvironment | 2019 |
Gold nanoparticle-oligonucleotide conjugates for the profiling of malignant melanoma phenotypes.
Topics: Biomarkers, Tumor; Cell Line; Cell Line, Tumor; Flow Cytometry; Gold; Humans; Inverted Repeat Sequences; Melanoma; Metal Nanoparticles; Molecular Probe Techniques; Oligonucleotides; Phenotype; Reverse Transcriptase Polymerase Chain Reaction | 2013 |
Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transfer.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Chemokines; Dendritic Cells; Gold; Hyperthermia, Induced; Immunotherapy, Adoptive; Inflammation Mediators; Lung Neoplasms; Lymph Nodes; Melanoma; Melanoma, Experimental; Mice; Myeloid Cells; Nanoshells; Ovalbumin; Phototherapy; Recurrence; T-Lymphocytes | 2013 |
An in vitro study on the photosensitivity of 5-aminolevulinic acid conjugated gold nanoparticles.
Topics: Aminolevulinic Acid; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Radiation; Gold; Humans; Melanoma; Nanocapsules; Photochemotherapy; Photosensitizing Agents; Radiation Tolerance; Treatment Outcome | 2013 |
Gold(I) biscarbene complexes derived from vascular-disrupting combretastatin A-4 address different targets and show antimetastatic potential.
Topics: Actin Cytoskeleton; Animals; Antineoplastic Agents; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Resistance, Neoplasm; G2 Phase Cell Cycle Checkpoints; Gold; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; Melanoma; Methane; Mice; Mice, Inbred BALB C; Neovascularization, Physiologic; Tubulin | 2014 |
Range verification for eye proton therapy based on proton-induced x-ray emissions from implanted metal markers.
Topics: Eye; Feasibility Studies; Fiducial Markers; Gold; Melanoma; Monte Carlo Method; Proton Therapy; Silver; Uveal Neoplasms; X-Rays | 2014 |
Nanoscale integrin ligand patterns determine melanoma cell behavior.
Topics: Actins; Cell Adhesion; Cell Count; Cell Line, Tumor; Cytoskeleton; Dose-Response Relationship, Drug; Glass; Gold; Humans; Integrin alphaVbeta3; Ligands; Melanoma; Metal Nanoparticles; Nanostructures; Peptides, Cyclic | 2014 |
Rapid synthesis of cyclic RGD conjugated gold nanoclusters for targeting and fluorescence imaging of melanoma A375 cells.
Topics: Cell Line, Tumor; Fluorescence; Gold; Humans; Integrin alphaVbeta3; MCF-7 Cells; Melanoma; Nanostructures; Optical Imaging; Peptides, Cyclic; Photoelectron Spectroscopy; Spectroscopy, Fourier Transform Infrared | 2015 |
An electrochemical immunosensing method for detecting melanoma cells.
Topics: Antibodies; Antibodies, Immobilized; Biosensing Techniques; Gold; Humans; Immunoassay; Lab-On-A-Chip Devices; Melanoma; Metal Nanoparticles; Microfluidic Analytical Techniques; Neoplastic Cells, Circulating; Receptor, Melanocortin, Type 1 | 2015 |
Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticles.
Topics: Adult; Biosensing Techniques; Cell Line, Tumor; Cell Survival; Gene Knockdown Techniques; Gold; GTP-Binding Protein alpha Subunits; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Melanoma; Metal Nanoparticles; Mutation; Neoplasm Proteins; RNA, Messenger; RNA, Neoplasm; Uveal Neoplasms | 2015 |
Photo-thermal effect enhances the efficiency of radiotherapy using Arg-Gly-Asp peptides-conjugated gold nanorods that target αvβ3 in melanoma cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Gold; Humans; Hyperthermia, Induced; Infrared Rays; Integrin alphaVbeta3; Melanoma; Nanotubes; Oligopeptides; Phototherapy | 2015 |
Hybrid Theranostic Platform for Second Near-IR Window Light Triggered Selective Two-Photon Imaging and Photothermal Killing of Targeted Melanoma Cells.
Topics: Cell Death; Cell Line, Tumor; Diagnostic Imaging; Gold; Humans; Hyperthermia, Induced; Melanoma; Metal Nanoparticles; Nanotubes, Carbon; Photons; Phototherapy; Spectroscopy, Near-Infrared; Theranostic Nanomedicine | 2015 |
Targeting NEU Protein in Melanoma Cells with Non-Thermal Atmospheric Pressure Plasma and Gold Nanoparticles.
Topics: Cell Death; Cells, Cultured; Drug Synergism; Gene Expression Regulation, Neoplastic; Gold; Humans; Immunoconjugates; Melanoma; Metal Nanoparticles; Molecular Targeted Therapy; Plasma Gases; Proteolysis; Receptor, ErbB-2; Skin Neoplasms | 2015 |
Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
Topics: Brachytherapy; Choroid Neoplasms; Computer Simulation; Eye Neoplasms; Gold; Humans; Iodine Radioisotopes; Male; Melanoma; Metal Nanoparticles; Models, Biological; Models, Theoretical; Monte Carlo Method; Phantoms, Imaging; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Uveal Neoplasms; Water | 2015 |
Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.
Topics: Adult; Brachytherapy; Computer Simulation; Eye Neoplasms; Gold; Humans; Iodine Radioisotopes; Melanoma; Metal Nanoparticles; Monte Carlo Method; Organs at Risk; Palladium; Phantoms, Imaging; Radiometry; Radiotherapy Dosage; Water | 2016 |
Nanoparticle-dendrimer hybrid nanocapsules for therapeutic delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Arginine; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Dendrimers; Female; Gold; Melanoma; Mice; Mice, Inbred C57BL; Nanocapsules; Nanoparticles; Paclitaxel; Thiocarbamates | 2016 |
Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma.
Topics: Animals; Cell Movement; Cell Survival; Chitosan; Colloids; Endothelial Cells; Female; Gold; Humans; Ions; Light; Melanoma; Metal Nanoparticles; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Physiologic; Photochemistry; Receptors, CXCR4; Skin Neoplasms; Tumor Microenvironment | 2016 |
Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chick Embryo; Gold; Humans; Imidazoles; Iridium; Melanoma; Mice; Neovascularization, Pathologic; Platinum; Ruthenium; Xenograft Model Antitumor Assays | 2016 |
AFM and QCM-D as tools for the distinction of melanoma cells with a different metastatic potential.
Topics: Biomarkers, Tumor; Biosensing Techniques; Concanavalin A; Glucose; Glycosylation; Gold; Humans; Lung Neoplasms; Mannose; Melanocytes; Melanoma; Microscopy, Atomic Force; Polysaccharides; Quartz Crystal Microbalance Techniques; Surface Properties | 2017 |
Enhancement of radiosensitivity of melanoma cells by pegylated gold nanoparticles under irradiation of megavoltage electrons.
Topics: Animals; Cell Line, Tumor; Cell Survival; Electrons; Gold; Melanoma; Metal Nanoparticles; Mice; Nanocapsules; Polyethylene Glycols; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Treatment Outcome | 2017 |
Gold nanoparticles as dose-enhancement agent for kilovoltage X-ray therapy of melanoma.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Gold; Humans; Melanoma; Metal Nanoparticles; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radiotherapy, High-Energy; Skin; Skin Neoplasms; X-Rays | 2017 |
High-throughput quantitation of inorganic nanoparticle biodistribution at the single-cell level using mass cytometry.
Topics: Animals; Dendritic Cells; Drug Carriers; Female; Gold; Mass Spectrometry; Melanoma; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Single-Cell Analysis; Tissue Distribution; Vaccines | 2017 |
Transdermal Gene Delivery by Functional Peptide-Conjugated Cationic Gold Nanoparticle Reverses the Progression and Metastasis of Cutaneous Melanoma.
Topics: Administration, Cutaneous; Gene Transfer Techniques; Gold; Humans; Melanoma; Metal Nanoparticles; Skin; Skin Neoplasms | 2017 |
3D imaging of mammalian cells with ion-abrasion scanning electron microscopy.
Topics: Cell Line, Tumor; Cytological Techniques; Eukaryotic Cells; Gold; Humans; Imaging, Three-Dimensional; Intracellular Membranes; Melanocytes; Melanoma; Melanosomes; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Mitochondria; Organelles; Quantum Dots; Staining and Labeling | 2009 |
Gene gun delivery systems for cancer vaccine approaches.
Topics: Animals; Cancer Vaccines; Dermis; DNA; Epidermis; Gene Expression Regulation; Gene Transfer Techniques; Genes, Reporter; Gold; Humans; Lung Neoplasms; Melanoma; Mice | 2009 |
Simple PEG conjugation of SPIO via an Au-S bond improves its tumor targeting potency as a novel MR tumor imaging agent.
Topics: Animals; Cell Line, Tumor; Dextrans; Ferric Compounds; Ferrosoferric Oxide; Gold; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Melanoma; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Neoplasms; Polyethylene Glycols; Sulfur | 2010 |
Hairpin DNA coated gold nanoparticles as intracellular mRNA probes for the detection of tyrosinase gene expression in melanoma cells.
Topics: Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Gold; Humans; Inverted Repeat Sequences; Melanoma; Microscopy, Confocal; Microscopy, Fluorescence; Monophenol Monooxygenase; Nanoparticles; Oligonucleotides; RNA, Messenger; Sulfhydryl Compounds | 2010 |
Photothermal multispectral image cytometry for quantitative histology of nanoparticles and micrometastasis in intact, stained and selectively burned tissues.
Topics: Animals; Biomarkers, Tumor; Gold; Hot Temperature; Image Cytometry; Laser Scanning Cytometry; Lymph Nodes; Lymphatic Metastasis; Melanins; Melanoma; Metal Nanoparticles; Mice; Mice, Nude; Nanotubes, Carbon; Neoplasm Transplantation; Photochemistry; Skin Neoplasms | 2010 |
Xanthan/chitosan gold chip for metal enhanced protein biomarker detection.
Topics: Biomarkers, Tumor; Biosensing Techniques; Cell Line, Tumor; Chitosan; Equipment Design; Equipment Failure Analysis; Gold; Humans; Immunoassay; Melanoma; Neoplasm Proteins; Polysaccharides, Bacterial; Protein Array Analysis; Spectrometry, Fluorescence | 2011 |
Enhanced photoacoustic detection of melanoma cells using gold nanoparticles.
Topics: Acoustics; Biomarkers, Tumor; Cell Line, Tumor; Cell Separation; Flow Cytometry; Gold; Humans; Lasers, Semiconductor; Melanoma; Metal Nanoparticles; Molecular Probe Techniques; Neoplastic Cells, Circulating; Pattern Recognition, Automated; Skin Neoplasms | 2011 |
Off-resonance plasmonic enhanced femtosecond laser optoporation and transfection of cancer cells.
Topics: Cell Line, Tumor; Cell Survival; Gene Transfer Techniques; Genetic Therapy; Gold; Humans; Lasers; Melanoma; Nanoparticles; Skin Neoplasms; Transfection | 2012 |
RGD-conjugated gold nanorods induce radiosensitization in melanoma cancer cells by downregulating α(v)β₃ expression.
Topics: Analysis of Variance; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Down-Regulation; Gold; Humans; Integrin alphaVbeta3; Melanoma; Nanotubes; Oligopeptides; Radiation-Sensitizing Agents | 2012 |
Comparative cytotoxicity of gold-doxorubicin and InP-doxorubicin conjugates.
Topics: Animals; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Synergism; Gold; Indium; Melanoma; Mice; Nanocapsules; Phosphines | 2012 |
THE INTRALYMPHATIC ADMINISTRATION OF RADIOACTIVE ISOTOPES AND CANCER CHEMOTHERAPEUTIC DRUGS.
Topics: Abdominal Neoplasms; Angiography; Breast Neoplasms; Geriatrics; Gold; Humans; Injections; Iodine Isotopes; Leukemia; Lymphatic Metastasis; Lymphatic System; Lymphography; Lymphoma; Lymphoma, Non-Hodgkin; Melanoma; Melphalan; Methotrexate; Neoplasms; Radioisotopes; Radionuclide Imaging; Retroperitoneal Neoplasms; Scandium; Thiotepa; Yttrium | 1964 |
Introduction of tyramide signal amplification (TSA) to pre-embedding nanogold-silver staining at the electron microscopic level.
Topics: Autoantigens; Cell Line, Tumor; Gold; Golgi Apparatus; Humans; Immunohistochemistry; Melanoma; Membrane Proteins; Microscopy, Electron; Silver Staining; Tyramine | 2005 |
Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models.
Topics: Animals; Cell Line, Tumor; Gold; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Nanoparticles; Organ Specificity; Particle Size; Prostatic Neoplasms; Tissue Distribution | 2007 |
Molecular mechanisms of action of auranofin and other gold complexes as related to their biologic activities.
Topics: Anti-Inflammatory Agents; Antibody Formation; Antineoplastic Agents; Arthritis, Rheumatoid; Auranofin; Aurothioglucose; Cell Survival; Cells, Cultured; DNA, Superhelical; Gold; Humans; Melanoma; Metallothionein; Structure-Activity Relationship | 1983 |
Radiotherapy of choroidal melanoma with iodine-125.
Topics: Choroid Neoplasms; Gold; Humans; Iodine Radioisotopes; Melanoma; Middle Aged; Neoplasm Metastasis; Radiotherapy Dosage | 1980 |
The uptake of uridine in the nucleolus occurs in the dense fibrillar component. Immunogold localization of incorporated digoxigenin-UTP at the electron microscopic level.
Topics: Animals; Cell Nucleolus; Digoxigenin; Gold; Horses; Humans; Lymphocyte Activation; Lymphocytes; Melanoma; Microscopy, Electron; Molecular Probes; Transcription, Genetic; Uridine Triphosphate | 1993 |
A shadow-casting technique for the examination of the surface topography of cultured cells.
Topics: Aluminum; Cell Membrane; Cells, Cultured; Colonic Neoplasms; Cytological Techniques; Female; Gold; Melanoma; Palladium; Rotation; Uterus | 1975 |
Ultrastructural localization of HMB-45 binding sites.
Topics: Antibodies, Monoclonal; Binding Sites, Antibody; Dysplastic Nevus Syndrome; Gold; Humans; Immunohistochemistry; Melanins; Melanocytes; Melanoma; Microscopy, Electron; Organelles; Skin | 1991 |
The melanoma proteoglycan: restricted expression on microspikes, a specific microdomain of the cell surface.
Topics: Aggrecans; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Adhesion; Cell Compartmentation; Cell Membrane; Chondroitin Sulfate Proteoglycans; Epitopes; Extracellular Matrix Proteins; Glycoproteins; Gold; Humans; Lectins, C-Type; Melanoma; Microscopy, Electron; Neoplasm Proteins; Proteoglycans | 1986 |
Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexes.
Topics: Animals; Antineoplastic Agents; Auranofin; Aurothioglucose; Cell Survival; Cells, Cultured; Gold; Leukemia P388; Melanoma; Mice; Solubility; Structure-Activity Relationship | 1986 |
Antimicrobial and anticancer activity of tetrahedral, chelated, diphosphine silver(I) complexes: comparison with copper and gold.
Topics: Animals; Bacteria; Blood; Candida albicans; Chemical Phenomena; Chemical Precipitation; Chemistry; Copper; Enterococcus faecalis; Glutathione; Gold; Humans; Leukemia P388; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Spectroscopy; Melanoma; Mice; Neoplasms, Experimental; Organophosphorus Compounds; Silver; Staphylococcus aureus | 1988 |
The use of video to monitor continuous gold laser photoradiation treatment of an ocular melanoma.
Topics: Eye Neoplasms; Gold; Humans; Laser Therapy; Melanoma; Television | 1988 |
Choroidal melanoma: I-125 plaque therapy.
Topics: Brachytherapy; Choroid Neoplasms; Gold; Humans; Iodine Radioisotopes; Melanoma; Middle Aged; Radiotherapy Dosage | 1988 |
Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.
Topics: Animals; Antineoplastic Agents; Auranofin; Aurothioglucose; Cell Cycle; Cell Survival; Drug Evaluation, Preclinical; Gold; Kinetics; Leukemia P388; Leukemia, Experimental; Melanoma; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Tumor Stem Cell Assay | 1985 |